HALO

Neutral

Form 4 Halozyme Therapeutics Inc For: 30 June By Investing.com

This article reports on a Form 4 filing for Halozyme Therapeutics Inc., covering the period up to June 30. Form 4 filings are used to disclose changes...

Investing.com Canada 2 days ago 0

Bullish

Halozyme names David Ramsay as president drug delivery By Investing.com

Halozyme Therapeutics, Inc. has appointed David Ramsay as President Drug Delivery, a newly created role where he will oversee the growth of the compan...

Investing.com Canada 2 days ago 0

Neutral

[144] HALOZYME THERAPEUTICS, INC. SEC Filing

This article reports on a Form 144 SEC filing by HALOZYME THERAPEUTICS, INC. The filing, accepted on June 29, 2026, details a proposed sale of securit...

Stock Titan 3 days ago 0

Neutral

Ifrah Financial Services Inc. Acquires New Shares in Halozyme Therapeutics, Inc. $HALO

Ifrah Financial Services Inc. bought a new stake in Halozyme Therapeutics, Inc. (NASDAQ:HALO – Free Report) during the 1st quarter, according to the c...

watchlistnews 4 days ago 0

Neutral

Price to sales forward of Halozyme Therapeutics, Inc. – FWB:RV7

This article provides the "Price to sales forward" metric for Halozyme Therapeutics, Inc. (FWB:RV7) on the TradingView platform. It indicates that the...

TradingView 4 days ago 0

Neutral

Faithward Advisors LLC Takes Position in Halozyme Therapeutics, Inc. $HALO

Faithward Advisors LLC acquired a new stake in Halozyme Therapeutics, Inc. (NASDAQ:HALO – Free Report) in the 4th quarter, HoldingsChannel reports. Th...

themarketsdaily 2 weeks ago 0